North China Pharmaceutical obtains Clinical Trial Permission on anidulafungin
On 21 May, 2016, North China Pharmaceutical Co., Ltd. (North China Pharmaceutical) released a notice on the latest information about its application for the Clinical Trial Permission on anidulafungin injection preparation (50 mg). On 25 May, the comp...
Vitamins China E-News 201605